Keyphrases
Pancreatic Cancer
100%
Pancreatic Cancer Risk
26%
Confidence Interval
23%
Pancreatic Ductal Adenocarcinoma
22%
Tumor
22%
Whole Genome
22%
Pan-cancer Analysis
22%
Genome-wide Association Study
18%
Familial Adenomatous Polyposis
17%
Odds Ratio
17%
Colorectal Cancer
17%
Familial Pancreatic Cancer
13%
Cancer Types
13%
In Cancer
13%
Cancer Cases
12%
Pancreatic Adenocarcinoma
12%
Germline mutation
12%
Human Cancer
11%
Germ Cells
10%
Hereditary Colorectal Cancer Syndromes
10%
Cancer Genome Atlas
9%
Single nucleotide Polymorphism
9%
First-degree Relatives
8%
Proband
8%
Genetic Testing
8%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
8%
Risk Factors
8%
Kindred
8%
Family History
7%
Diabetes
7%
Cancer Risk
7%
Cancer Patients
7%
Adenomatous Polyposis Coli Gene
7%
Gene mutation
6%
Genetic Counseling
6%
Susceptibility Loci
6%
BRCA2
6%
Lung Cancer
6%
Gene Testing
6%
SNP
5%
Pooled Analysis
5%
Cancer Families
5%
Polymorphism
5%
Molecular Characterization
5%
Colon Cancer
5%
Tumor Subtype
5%
Cancer Genes
5%
High Risk
5%
Cancer Genome
5%
Biochemistry, Genetics and Molecular Biology
Germ Cell
20%
Allele
19%
Genome-Wide Association Study
19%
Genomics
19%
Germline
18%
Single-Nucleotide Polymorphism
16%
Genetics
15%
Germline Mutation
13%
Pan-cancer
13%
Gene Mutation
12%
Colon
11%
Carcinogenesis
11%
Proband
10%
Prevalence
10%
Genotyping
9%
BRCA2
9%
Case-Control Study
8%
DNA Mismatch Repair
8%
Single Nucleotide Polymorphism
8%
Cyclin Dependent Kinase Inhibitor 2A
7%
Genetic Divergence
6%
Whole Genome Sequencing
6%
Oncogene
6%
DNA Methylation
6%
Adenomatous Polyposis Coli
6%
Cancer Cell
5%
Candidate Gene
5%
Pedigree
5%
Telomere Length
5%
Genetic Screening
5%
Medicine and Dentistry
Pancreas Cancer
59%
Malignant Neoplasm
31%
Neoplasm
18%
Pancreas Adenocarcinoma
15%
Cancer Risk
11%
Colorectal Carcinoma
11%
Cancer
10%
Diseases
9%
Diabetes
8%
Familial Adenomatous Polyposis
7%
Family History
7%
Odds Ratio
6%
Genome Wide Association Study
6%
Gene Mutation
6%
Genetic Screening
6%
Genetic Counseling
5%
Familial Pancreatic Cancer
5%
Hereditary Nonpolyposis Colorectal Cancer
5%
Single Nucleotide Polymorphism
5%
Pooled Analysis
5%
Cancer Types
5%